Literature DB >> 17912577

Characteristic electron microscopic findings in the skin of patients with fibromyalgia: preliminary study.

Seong-Ho Kim1, Dong Hoon Kim, Dong-Ho Oh, Daniel J Clauw.   

Abstract

This blinded study was done to determine if there are any abnormal electron microscopic (EM) findings in the skin of fibromyalgia syndrome (FMS) patients, which might contribute to or be due to the increased pain sensitivity seen in this condition. Skin biopsy samples were obtained from 13 FMS patients and 5 control subjects. All tissues were prepared for EM examination by immediate prefixation in 2.5% glutaraldehyde for 2 h and postfixation in 1% osmium acid for 24 h. Ultrathin sections on grids were stained by uranyl acetate and lead citrate. Biopsies were read by an individual without knowledge of participant status. Five skin biopsies from healthy controls showed relatively even distribution of variegated sized unmyelinated axons sheathed well by complicatedly folded Schwann cell membranes. In tissues from 9/13 FMS patients, unmyelinated Schwann cells were noted to be ballooned, whereas this finding was not noted in any controls (p = 0.029). Axons in most patients trended towards being localized in the periphery of the unmyelinated Schwann cell sheaths (p = 0.002). Particularly, peripheral localization of axon in the unmyelinated Schwann cell sheath had a strong relationship with ballooning of Schwann cell (p = 0.042), simplified folding of Schwann cell sheath (p = 0.039) and smaller axon (p = 0.034). Myelinated nerve fibers were unremarkable. The EM findings seen in the skin of FMS patients show unusual patterns of unmyelinated nerve fibers as well as associated Schwann cells. If these findings are replicated in a larger study, these abnormalities may contribute to, or be due to, the lower pain threshold seen in FMS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17912577     DOI: 10.1007/s10067-007-0739-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Collagen crosslinks in fibromyalgia.

Authors:  H Sprott; A Müller; H Heine
Journal:  Arthritis Rheum       Date:  1997-08

2.  Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition.

Authors:  Nancy Julien; Philippe Goffaux; Pierre Arsenault; Serge Marchand
Journal:  Pain       Date:  2005-03       Impact factor: 6.961

3.  Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.

Authors:  L A Aaron; M M Burke; D Buchwald
Journal:  Arch Intern Med       Date:  2000-01-24

Review 4.  Is there muscle pathology in fibromyalgia syndrome?

Authors:  R W Simms
Journal:  Rheum Dis Clin North Am       Date:  1996-05       Impact factor: 2.670

5.  Increased expression of N-methyl-D-aspartate receptor subunit 2D in the skin of patients with fibromyalgia.

Authors:  Seong-Ho Kim; Tae Jung Jang; Il Soo Moon
Journal:  J Rheumatol       Date:  2006-04       Impact factor: 4.666

6.  Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome.

Authors:  G Granges; G Littlejohn
Journal:  Arthritis Rheum       Date:  1993-05

Review 7.  The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia.

Authors:  D J Clauw
Journal:  Med Hypotheses       Date:  1995-05       Impact factor: 1.538

8.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05

9.  Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres.

Authors:  H Sprott; S Salemi; R E Gay; L A Bradley; G S Alarcón; S J Oh; B A Michel; S Gay
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

10.  Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia.

Authors:  Souzan Salemi; Janine Rethage; Uwe Wollina; Beat A Michel; Renate E Gay; Steffen Gay; Haiko Sprott
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

View more
  4 in total

Review 1.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

2.  Dermatologic manifestations of fibromyalgia.

Authors:  Valerie Laniosz; David A Wetter; Desiree A Godar
Journal:  Clin Rheumatol       Date:  2014-01-14       Impact factor: 2.980

Review 3.  Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis.

Authors:  Maya Levy Coles; Rotem Weissmann; Yosef Uziel
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-01       Impact factor: 3.054

4.  Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Leslie M Arnold; Mary Beth Blauwet; Katherine Tracy; Na Cai; Mark Walzer; Paul Blahunka; Gerard J Marek
Journal:  J Pain Res       Date:  2020-12-10       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.